Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Bladder Cancer

Free Subscription Articles published in Br J Cancer Retrieve available abstracts of 14 articles: HTML format Text format

Single Articles

January 2012
1. SIMPSON GR , Horvath A, Annels NE, Pencavel T, et al
   Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer.
   Br J Cancer. 2012 Jan 12. doi: 10.1038/bjc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
2. POLESEL J , Gheit T, Talamini R, Shahzad N, et al
   Urinary human polyomavirus and papillomavirus infection and bladder cancer risk.
   Br J Cancer. 2011 Nov 24. doi: 10.1038/bjc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. VILLADSEN SB , Bramsen JB, Ostenfeld MS, Wiklund ED, et al
   The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer.
   Br J Cancer. 2011 Nov 22. doi: 10.1038/bjc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
4. KEIDAR M , Walk R, Shashurin A, Srinivasan P, et al
   Cold plasma selectivity and the possibility of a paradigm shift in cancer therapy.
   Br J Cancer. 2011;105:1295-301.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. MUNKSGAARD PP , Mansilla F, Brems Eskildsen AS, Fristrup N, et al
   Low ANXA10 expression is associated with disease aggressiveness in bladder cancer.
   Br J Cancer. 2011 Oct 6. doi: 10.1038/bjc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. TANAKA N , Miyajima A, Kosaka T, Miyazaki Y, et al
   Acquired platinum resistance enhances tumour angiogenesis through angiotensin II type 1 receptor in bladder cancer.
   Br J Cancer. 2011 Oct 4. doi: 10.1038/bjc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   July 2011
7. ADHIM Z , Matsuoka T, Bito T, Shigemura K, et al
   In vitro and in vivo inhibitory effect of three Cox-2 inhibitors and epithelial-to-mesenchymal transition in human bladder cancer cell lines.
   Br J Cancer. 2011 Jul 12. doi: 10.1038/bjc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   May 2011
8. PRIDGEON SW , Heer R, Taylor GA, Newell DR, et al
   Thiothymidine combined with UVA as a potential novel therapy for bladder cancer.
   Br J Cancer. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   March 2011
9. FORSTER JA , Paul AB, Harnden P, Knowles MA, et al
   Expression of NRG1 and its receptors in human bladder cancer.
   Br J Cancer. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   February 2011
10. YOSHINO H , Chiyomaru T, Enokida H, Kawakami K, et al
    The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
11. LAMONT FR , Tomlinson DC, Cooper PA, Shnyder SD, et al
    Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo.
    Br J Cancer. 2011;104:75-82.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
12. MATSUDA R , Enokida H, Chiyomaru T, Kikkawa N, et al
    LY6K is a novel molecular target in bladder cancer on basis of integrate genome-wide profiling.
    Br J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
13. WU CF , Ng KF, Chen CS, Chang PL, et al
    Expression of parvin-beta is a prognostic factor for patients with urothelial cell carcinoma of the upper urinary tract.
    Br J Cancer. 2010;103:852-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2010
14. CHIYOMARU T , Enokida H, Tatarano S, Kawahara K, et al
    miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer.
    Br J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: